Investing Ideas Browse All Stocks Markets

Largest U.S. Pharmaceuticals & Biotech Stocks by Market Cap - Simply Wall St

Advanced Filters

Largest U.S. Pharmaceuticals & Biotech Stocks by Market Cap

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Aug 06, 2026

Discover large cap U.S. Pharmaceuticals & Biotech companies that are on the NYSE and NASDAQ. These Pharmaceuticals & Biotech Companies are organised by Market Cap.

715 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
LLY	US$1,191.94	3.2%	86.0%	US$1.0t	US$1,297.31	39.8	16.2%	0.6%
JNJ	US$256.98	0.5%	49.8%	US$620.8b	US$272.50	29.4	8.1%	2.1%
ABBV	US$246.20	-4.4%	23.8%	US$435.1b	US$273.39	69.4	24.8%	2.8%
MRK	US$128.37	-1.1%	59.7%	US$317.0b	US$136.65	99.9	30.3%	2.6%
AMGN	US$404.85	4.4%	42.2%	US$220.5b	US$374.69	25.0	6.8%	2.5%
TMO	US$580.02	0.6%	27.5%	US$213.7b	US$631.42	30.8	10.7%	0.3%
GILD	US$130.86	-0.3%	18.7%	US$163.5b	US$157.41	5.3	45.4%	2.5%
PFE	US$26.20	5.2%	8.1%	US$147.1b	US$28.83	34.4	6.6%	6.6%
DHR	US$199.98	1.9%	0.8%	US$140.4b	US$227.96	35.2	14.2%	0.8%
BMY	US$64.15	-1.1%	41.4%	US$130.0b	US$66.21	14.1	-6.9%	3.9%
VRTX	US$484.83	0.6%	29.1%	US$122.9b	US$559.28	27.9	14.0%	n/a
REGN	US$768.58	4.1%	37.3%	US$76.7b	US$833.54	17.7	12.0%	0.5%
RVMD	US$197.81	2.9%	466.0%	US$41.9b	US$213.66	28.0	61.4%	n/a
TEVA	US$34.81	-1.7%	113.7%	US$40.5b	US$41.20	57.5	28.8%	0%
A	US$141.34	1.9%	24.0%	US$39.9b	US$159.32	28.2	12.0%	0.7%
NTRA	US$274.62	1.8%	94.7%	US$39.3b	US$282.86	15.7	59.4%	n/a
WAT	US$399.70	5.1%	43.8%	US$39.3b	US$433.39	235.5	35.8%	n/a
IQV	US$232.43	-2.3%	29.9%	US$38.9b	US$275.17	27.8	14.8%	n/a
ONC	US$329.80	2.4%	10.6%	US$37.2b	US$429.34	57.2	27.9%	n/a
RPRX	US$57.26	-3.0%	54.7%	US$33.3b	US$63.25	31.2	43.1%	1.6%
ZTS	US$77.27	1.6%	-47.9%	US$31.2b	US$110.19	12.1	5.5%	2.7%
ALNY	US$228.72	11.3%	-47.4%	US$30.6b	US$375.76	39.5	24.8%	n/a
BIIB	US$206.28	-0.8%	61.5%	US$30.5b	US$235.32	36.5	22.1%	n/a
ILMN	US$193.72	-5.5%	102.8%	US$30.2b	US$195.83	35.5	12.4%	n/a

Page 1 of 30